Kneat.com enters service deal with biopharma provider

Executive Summary

• Kneat.com Inc. has signed a master service agreement with a major global biopharma research and manufacturing provider (headquartered in Europe with 13,000+ employees and 60+ locations).
• The client will deploy Kneat's digital validation platform for equipment validation at several manufacturing sites worldwide.
• Kneat expects the client to expand its use of the platform enterprise-wide over time, reinforcing Kneat's position as an industry standard and supporting continued revenue growth.

Key Details

• Transaction Type: Master Service Agreement for digital validation services.
• Counterparty: A leading global biopharma research and manufacturing technologies provider (specific name not disclosed in the release).
• Scope of Deployment: Initial deployment at several manufacturing sites worldwide, with expectations for enterprise-wide expansion over time.
• Value Proposition: The client selected Kneat based on a comprehensive evaluation, citing proven ability to deliver measurable return on investment and a strong record of success with global life science leaders.
• Operational Impact: The partnership aims to harmonize and standardize validation processes across the client's global operations, driving operational excellence.
• Company Background: Kneat Gx is ISO 9001 and ISO 27001 certified, fully validated, and compliant with 21 CFR Part 11/Annex 11. Independent studies indicate it can reduce validation documentation man-hours by up to 50% and accelerate review/approval cycles by up to 50%.

Notable Quotes

• "Welcoming one of the world's foremost biopharma processing solution providers is an exciting start to 2026 and builds on the strong momentum we achieved in 2025. This partnership underscores Kneat's growing role across the broader pharmaceutical manufacturing supply chain, where quality and compliance are highly valued. Our shared mission is to help life sciences companies deliver therapies to patients to the highest standards of safety and quality," said Eddie Ryan, chief executive officer of Kneat.